Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 18-Sep-24 5:46 PM View:  | Bizily Scott Chief Legal Officer | 4d Molecular Therapeutics, ... (FDMT) | 16-Sep-24 | Planned Option Sale | 500 | $16.33 | $8,165.00 | (7%) 7.28K to 6.78K | |
| 18-Sep-24 5:46 PM View: | Bizily Scott Chief Legal Officer | 4d Molecular Therapeutics, ... (FDMT) | 16-Sep-24 | Option Exercise | 500 | $6.49 | $3,245.00 | 7% 6.78K to 7.28K | |
| 18-Jul-24 8:22 PM View: | Bizily Scott Chief Legal Officer | 4d Molecular Therapeutics, ... (FDMT) | 16-Jul-24 | Planned Option Sale | 1,750 | $27.11 | $47,442.50 | (21%) 8.53K to 6.78K | |
| 18-Jul-24 8:22 PM View: | Bizily Scott Chief Legal Officer | 4d Molecular Therapeutics, ... (FDMT) | 16-Jul-24 | Option Exercise | 1,750 | $7.60 | $13,295.00 | 26% 6.78K to 8.53K | |
| 15-Jul-24 6:13 PM View: | Bizily Scott Chief Legal Officer | 4d Molecular Therapeutics, ... (FDMT) | 11-Jul-24 | Planned Option Sale | 1,996 | $25.00 | $49,900.00 | (23%) 8.78K to 6.78K | |
| 15-Jul-24 6:13 PM View: | Bizily Scott Chief Legal Officer | 4d Molecular Therapeutics, ... (FDMT) | 11-Jul-24 | Option Exercise | 1,996 | $15.78 | $31,496.90 | 29% 6.78K to 8.78K | |
| 12-Jul-24 5:46 PM View: | Kirn David Chief Executive Officer Director | 4d Molecular Therapeutics, ... (FDMT) | 10-Jul-24 | Planned Option Sale | 12,923 | $22.49 | $290,598.00 | (1%) 1.07M to 1.06M | |
| 12-Jul-24 5:46 PM View: | Kirn David Chief Executive Officer Director | 4d Molecular Therapeutics, ... (FDMT) | 10-Jul-24 | Option Exercise | 12,923 | $14.55 | $188,077.00 | 1% 1.06M to 1.07M | |
| 03-Jul-24 5:11 PM View: | Bizily Scott Chief Legal Officer | 4d Molecular Therapeutics, ... (FDMT) | 01-Jul-24 | Planned Option Sale | 4,248 | $21.36 | $90,757.70 | (71%) 5.99K to 1.74K | |
| 03-Jul-24 5:11 PM View: | Bizily Scott Chief Legal Officer | 4d Molecular Therapeutics, ... (FDMT) | 01-Jul-24 | Option Exercise | 4,248 | $7.55 | $32,089.30 | 245% 1.74K to 5.99K | |
| 26-Jun-24 5:07 PM View: | Kirn David Chief Executive Officer Director | 4d Molecular Therapeutics, ... (FDMT) | 24-Jun-24 | Option Exercise | 12,930 | $14.42 | $186,451.00 | 1% 1.06M to 1.07M | |
| 26-Jun-24 5:07 PM View: | Kirn David Chief Executive Officer Director | 4d Molecular Therapeutics, ... (FDMT) | 24-Jun-24 | Planned Option Sale | 12,930 | $23.10 | $298,711.00 | (1%) 1.07M to 1.06M | |
| 20-Jun-24 4:59 PM View: | Bizily Scott Chief Legal Officer | 4d Molecular Therapeutics, ... (FDMT) | 17-Jun-24 | Planned Option Sale | 1,750 | $23.71 | $41,493.60 | (50%) 3.49K to 1.74K | |
| 20-Jun-24 4:59 PM View: | Bizily Scott Chief Legal Officer | 4d Molecular Therapeutics, ... (FDMT) | 17-Jun-24 | Option Exercise | 1,750 | $7.60 | $13,295.00 | 101% 1.74K to 3.49K | |
| 20-May-24 8:35 PM View: | Bizily Scott Chief Legal Officer | 4d Molecular Therapeutics, ... (FDMT) | 16-May-24 | Option Exercise | 1,750 | $7.60 | $13,295.00 | 101% 1.74K to 3.49K | |
| 20-May-24 8:35 PM View: | Bizily Scott Chief Legal Officer | 4d Molecular Therapeutics, ... (FDMT) | 16-May-24 | Planned Option Sale | 1,750 | $25.45 | $44,541.00 | (50%) 3.49K to 1.74K | |
| 18-Apr-24 8:48 PM View: | Bizily Scott Chief Legal Officer | 4d Molecular Therapeutics, ... (FDMT) | 16-Apr-24 | Option Exercise | 1,750 | $7.60 | $13,295.00 | 101% 1.74K to 3.49K | |
| 18-Apr-24 8:48 PM View: | Bizily Scott Chief Legal Officer | 4d Molecular Therapeutics, ... (FDMT) | 16-Apr-24 | Planned Option Sale | 1,750 | $25.74 | $45,045.00 | (50%) 3.49K to 1.74K | |
| 03-Apr-24 7:18 PM View: | Bizily Scott Chief Legal Officer | 4d Molecular Therapeutics, ... (FDMT) | 01-Apr-24 | Option Exercise | 8,153 | $12.54 | $102,224.00 | 469% 1.74K to 9.89K | |
| 03-Apr-24 7:18 PM View: | Bizily Scott Chief Legal Officer | 4d Molecular Therapeutics, ... (FDMT) | 01-Apr-24 | Planned Option Sale | 8,153 | $31.78 | $259,102.00 | (82%) 9.89K to 1.74K | |
| 29-Mar-24 4:52 PM View: | Bizily Scott Chief Legal Officer | 4d Molecular Therapeutics, ... (FDMT) | 27-Mar-24 | Planned Option Sale | 5,833 | $35.04 | $204,410.00 | (77%) 7.57K to 1.74K | |
| 29-Mar-24 4:52 PM View: | Bizily Scott Chief Legal Officer | 4d Molecular Therapeutics, ... (FDMT) | 27-Mar-24 | Option Exercise | 5,833 | $25.98 | $151,541.00 | 336% 1.74K to 7.57K | |
| 20-Mar-24 4:40 PM View: | Bizily Scott Chief Legal Officer | 4d Molecular Therapeutics, ... (FDMT) | 18-Mar-24 | Option Exercise | 1,750 | $7.60 | $13,295.00 | 101% 1.74K to 3.49K | |
| 20-Mar-24 4:40 PM View: | Bizily Scott Chief Legal Officer | 4d Molecular Therapeutics, ... (FDMT) | 18-Mar-24 | Planned Option Sale | 1,750 | $31.27 | $54,722.50 | (50%) 3.49K to 1.74K | |
| 29-Feb-24 6:01 PM View: | Bizily Scott Chief Legal Officer | 4d Molecular Therapeutics, ... (FDMT) | 27-Feb-24 | Option Exercise | 1,909 | $20.24 | $38,638.20 | 110% 1.74K to 3.65K | (10%) |
| 29-Feb-24 6:01 PM View: | Bizily Scott Chief Legal Officer | 4d Molecular Therapeutics, ... (FDMT) | 27-Feb-24 | Planned Private Option Sale | 1,909 | $30.00 | $57,270.00 | (52%) 3.65K to 1.74K | |
| 21-Feb-24 5:41 PM View: | Bizily Scott Chief Legal Officer | 4d Molecular Therapeutics, ... (FDMT) | 16-Feb-24 | Planned Option Sale | 1,750 | $27.67 | $48,422.50 | (50%) 3.49K to 1.74K | |
| 21-Feb-24 5:41 PM View: | Bizily Scott Chief Legal Officer | 4d Molecular Therapeutics, ... (FDMT) | 16-Feb-24 | Option Exercise | 1,750 | $7.60 | $13,295.00 | 101% 1.74K to 3.49K | |
| 12-Feb-24 9:04 PM View: | Bizily Scott Chief Legal Officer | 4d Molecular Therapeutics, ... (FDMT) | 08-Feb-24 | Option Exercise | 6,244 | $10.18 | $63,586.20 | 359% 1.74K to 7.98K | |
| 12-Feb-24 8:22 PM View: | Kirn David Chief Executive Officer Director | 4d Molecular Therapeutics, ... (FDMT) | 08-Feb-24 | Private Sale (Planned) | 92,001 | $27.13 | $2,495,820.00 | (8%) 1.15M to 1.06M | |
| 12-Feb-24 9:04 PM View: | Bizily Scott Chief Legal Officer | 4d Molecular Therapeutics, ... (FDMT) | 08-Feb-24 | Planned Option Sale | 6,244 | $27.50 | $171,710.00 | (78%) 7.98K to 1.74K | |
| 07-Feb-24 8:32 PM View: | Kim Robert Young Chief Medical Officer | 4d Molecular Therapeutics, ... (FDMT) | 05-Feb-24 | Sale (Planned) | 552 | $30.05 | $16,587.60 | (35%) 1.59K to 1.04K | |
| 07-Feb-24 8:32 PM View: | Kim Robert Young Chief Medical Officer | 4d Molecular Therapeutics, ... (FDMT) | 05-Feb-24 | Option Exercise | 24,000 | $15.28 | $366,840.00 | 1505% 1.59K to 25.59K | |
| 07-Feb-24 8:32 PM View: | Kim Robert Young Chief Medical Officer | 4d Molecular Therapeutics, ... (FDMT) | 05-Feb-24 | Planned Option Sale | 24,000 | $30.05 | $721,200.00 | (94%) 25.59K to 1.59K | |
| 25-Jan-24 4:59 PM View: | Kirn David Chief Executive Officer Director | 4d Molecular Therapeutics, ... (FDMT) | 23-Jan-24 | Market Sale (Planned) | 5,696 | $18.41 | $104,851.00 | (< 1%) 1.16M to 1.15M | 1% |
| 08-Jan-24 4:19 PM View: | Kirn David Chief Executive Officer Director | 4d Molecular Therapeutics, ... (FDMT) | 05-Jan-24 | Sale (Planned) | 28,237 | $19.57 | $552,478.00 | (2%) 1.19M to 1.16M | |
| 05-Jan-24 5:44 PM View: | Viking Global Investors Lp 10% Owner | 4d Molecular Therapeutics, ... (FDMT) | 04-Jan-24 | Market Sale | 540,000 | $19.53 | $10,546,200.00 | (11%) 4.79M to 4.25M | 7% |
| 08-Jan-24 4:19 PM View: | Kirn David Chief Executive Officer Director | 4d Molecular Therapeutics, ... (FDMT) | 04-Jan-24 | Private Sale (Planned) | 40,732 | $20.31 | $827,202.00 | (3%) 1.23M to 1.19M | |
| 08-Jan-24 4:19 PM View: | Kirn David Chief Executive Officer Director | 4d Molecular Therapeutics, ... (FDMT) | 18-Dec-23 | Market Sale (Planned) | 4,702 | $18.13 | $85,242.60 | (< 1%) 1.23M to 1.23M | (< 1%) |
| 08-Jan-24 4:19 PM View: | Kirn David Chief Executive Officer Director | 4d Molecular Therapeutics, ... (FDMT) | 15-Dec-23 | Market Sale (Planned) | 28,632 | $17.27 | $494,432.00 | (2%) 1.26M to 1.23M | (5%) |
| 12-Jun-23 6:23 PM View: | Bizily Scott Chief Legal and HR Officer | 4d Molecular Therapeutics, ... (FDMT) | 08-Jun-23 | Option Exercise | 3,750 | $8.04 | $30,150.00 | 216% 1.74K to 5.49K | |
| 12-Jun-23 6:23 PM View: | Bizily Scott Chief Legal and HR Officer | 4d Molecular Therapeutics, ... (FDMT) | 08-Jun-23 | Planned Option Sale | 3,750 | $20.85 | $78,187.50 | (68%) 5.49K to 1.74K | |
| 16-May-23 8:52 PM View: | Moretti August J Chief Financial Officer | 4d Molecular Therapeutics, ... (FDMT) | 15-May-23 | Option Exercise | 3,000 | $9.41 | $28,230.00 | 37% 8.04K to 11.04K | |
| 11-May-23 5:50 PM View: | Viking Global Investors Lp 10% Owner | 4d Molecular Therapeutics, ... (FDMT) | 09-May-23 | Private Purchase | 850,000 | $16.00 | $13,600,000.00 | 22% 3.94M to 4.79M | |
| 04-May-23 10:00 PM View: | Kirn David Chief Executive Officer Director | 4d Molecular Therapeutics, ... (FDMT) | 02-May-23 | Gift | 600,000 | -- | -- | (24%) 2.46M to 1.86M | |
| 04-May-23 10:00 PM View: | Kirn David Chief Executive Officer Director | 4d Molecular Therapeutics, ... (FDMT) | 02-May-23 | Gift | 600,000 | -- | -- | 32% 1.86M to 2.46M | |
| 25-Apr-23 6:44 PM View: | Bizily Scott Chief Legal and HR Officer | 4d Molecular Therapeutics, ... (FDMT) | 21-Apr-23 | Option Exercise | 3,750 | $8.04 | $30,150.00 | 178% 2.11K to 5.86K | |
| 25-Apr-23 6:44 PM View: | Bizily Scott Chief Legal and HR Officer | 4d Molecular Therapeutics, ... (FDMT) | 21-Apr-23 | Planned Option Sale | 3,750 | $20.00 | $75,000.00 | (64%) 5.86K to 2.11K | |
| 25-Apr-23 6:43 PM View: | Chacko Jacob Director | 4d Molecular Therapeutics, ... (FDMT) | 21-Apr-23 | Planned Option Sale | 5,000 | $20.05 | $100,270.00 | (100%) 5.0K to 0 | |
| 25-Apr-23 6:43 PM View: | Chacko Jacob Director | 4d Molecular Therapeutics, ... (FDMT) | 21-Apr-23 | Option Exercise | 5,000 | $9.41 | $47,050.00 | 100% 0 to 5.0K |
